Viridian Therapeutics, Inc. (VRDN)
28.67
-1.58
(-5.22%)
USD |
NASDAQ |
Mar 03, 10:26
Viridian Therapeutics Shareholders Equity (Quarterly) : 722.17M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 18.39M |
| ADMA Biologics, Inc. | 477.32M |
| Avantor, Inc. | 5.565B |
| Immunovant, Inc. | 986.14M |
| Plus Therapeutics, Inc. | 5.054M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 899.42M |
| Total Liabilities (Quarterly) | 177.25M |
| Debt to Equity Ratio | 0.0702 |
| Current Ratio | 12.65 |
| Net Debt Paydown Yield | -0.18% |